Shahbar, A.; Alawlqi, A.; Alhifany, A.; Noor, A.; Almutairi, A.R.; Alnuhait, M.
Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. J. Clin. Med. 2025, 14, 1811.
https://doi.org/10.3390/jcm14061811
AMA Style
Shahbar A, Alawlqi A, Alhifany A, Noor A, Almutairi AR, Alnuhait M.
Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine. 2025; 14(6):1811.
https://doi.org/10.3390/jcm14061811
Chicago/Turabian Style
Shahbar, Alaa, Abdulaziz Alawlqi, Abdullah Alhifany, Afnan Noor, Abdulaali R. Almutairi, and Mohammed Alnuhait.
2025. "Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials" Journal of Clinical Medicine 14, no. 6: 1811.
https://doi.org/10.3390/jcm14061811
APA Style
Shahbar, A., Alawlqi, A., Alhifany, A., Noor, A., Almutairi, A. R., & Alnuhait, M.
(2025). Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine, 14(6), 1811.
https://doi.org/10.3390/jcm14061811